Viewing Study NCT03159832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-04-06 @ 10:30 PM
Study NCT ID: NCT03159832
Status: UNKNOWN
Last Update Posted: 2017-05-19
First Post: 2017-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Insufficiency,Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Efficacy View
None PK/PD study View
None Renal Insufficiency View
None Type 2 Diabetes View